PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2013.45.1.74201345174-77Interstitial Pneumonitis after Treatment with Pemetrexed for Non-small Cell Lung CancerKyeong-Hyun Kim, Seo-Young Song, Kyu-Hyoung Lim, Seon-Sook Han, Se-Hyun Kim, Jun Hwi Cho, Chan Woo Park, Seoungkoo Lee, Hui-Young Leehttp://www.e-crt.org/upload/pdf/crt-45-74.pdf, http://www.e-crt.org/upload/pdf/crt-45-74.pdf
Lung Cancer10.1016/s0169-5002(15)50068-8201587S2769: Pemetrexed in the treatment of non-small-cell lung cancerR. Cash, A. Dangoorhttps://api.elsevier.com/content/article/PII:S0169500215500688?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500215500688?httpAccept=text/plain
Lung Cancer: Targets and Therapy10.2147/lctt.s73268201513Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancerSeigo Minami, Takashi Kijimahttps://www.dovepress.com/getfile.php?fileID=23477
Lung Cancer: Targets and Therapy10.2147/lctt.s115422010101The role of maintenance pemetrexed in the treatment of non-small-cell lung cancer Rafiihttps://www.dovepress.com/getfile.php?fileID=7146
Lung Cancer10.1016/j.lungcan.2020.08.0222020150249-251Radiation pneumonitis after definitive chemoradiation and durvalumab for non-small cell lung cancerKhinh Ranh Voong, Jarushka Naidoohttps://api.elsevier.com/content/article/PII:S0169500220305961?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500220305961?httpAccept=text/plain
Lung Cancer10.1016/j.lungcan.2010.09.0072010702230Corrigendum to “Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer” [Lung Cancer 69S1 (2010) S4–S10]https://api.elsevier.com/content/article/PII:S0169500210004381?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500210004381?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(17)30117-42017103S3167: Outcomes of patients in South Yorkshire who received maintenance pemetrexed treatment for non-squamous, non-small-cell cancer after induction chemotherapy with pemetrexed and cisplatinM. Kakoudaki, R. Marshall, S.J. Danson, P.M. Fisher, M.Q. Hatton, C.E. Lee, T. Das, E. Bates, P. Woll, F. Taylorhttps://api.elsevier.com/content/article/PII:S0169500217301174?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S0169500217301174?httpAccept=text/xml
Cancer Treatment Reviews10.1016/j.ctrv.2009.02.0022009354364-373Pemetrexed in first-line treatment of non-small cell lung cancerEmilio Esteban, Marta Casillas, Alejo Cassinellohttps://api.elsevier.com/content/article/PII:S0305737209000206?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0305737209000206?httpAccept=text/plain
Chest10.1016/j.chest.2019.08.150220191564A1716THE RISK OF TREATMENT WITH PEMETREXED PLUS PLATINUM FOLLOWED BY MAINTENANCE WITH PEMETREXED FOR PATIENTS WITH ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER CONCURRENT WITH INTERSTITIAL LUNG DISEASETetsuo Fujita, TSUGUKO KUROKI, YUKA SHIRAISHI, Hiroyuki Amano, makoto nakamura, Satoshi Hirano, Hiroshi Tabeta, SUKEYUKI NAKAMURAhttps://api.elsevier.com/content/article/PII:S0012369219330004?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0012369219330004?httpAccept=text/plain
Clinical and Translational Oncology10.1007/s12094-007-0106-4200799578-581Docetaxel-induced interstitial pneumonitis following non-small-cell lung cancer treatmentC. Grande, M. J. Villanueva, G. Huidobro, J. Casalhttp://link.springer.com/content/pdf/10.1007/s12094-007-0106-4.pdf, http://link.springer.com/article/10.1007/s12094-007-0106-4/fulltext.html, http://link.springer.com/content/pdf/10.1007/s12094-007-0106-4